Latest Cost Management News

Genesis Energy posted a robust FY26 with Normalised EBITDAF up 11% to $522m, driven by margin growth and strategic investments in renewables and battery storage. A $400m equity raise bolstered its balance sheet as it accelerates New Zealand’s energy transition.

Summerset Group Holdings posted a 92% jump in half-year net profit to NZ$171.4 million, driven by strong sales and disciplined cash management. The company also updated its dividend policy to align payouts with operating cash flow, reflecting its maturing portfolio and cautious growth approach.

CTI Logistics (ASX:CLX) posted a 69% jump in net profit to $24 million for FY26, driven by robust transport volumes, logistics growth and a $74 million uplift in property valuations. The company also declared a 14 cents per share fully franked dividend.

Ainsworth Game Technology’s first half 2026 results reveal a sharp revenue drop driven by North American and Latin American market pressures, offset partially by Asia Pacific growth and a key patent licensing deal.

Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.

Calix Limited posted a 16% revenue increase to $39.2 million in FY26 driven by strong growth in its Magnesia business, while reporting a substantial net loss of $51 million largely due to a one-off impairment. The company advanced key industrial decarbonisation projects and strengthened strategic partnerships, focusing on capital-light commercialisation.

FAR Limited swung to a US$1.44 million profit for H1 2026, driven by contingent payments from its Senegal asset sale, and completed a substantial A$32.3 million capital return to shareholders.

FOS Capital reported a 12% revenue decline and an EBITDA loss of $0.5 million in FY26, impacted by softer market conditions and project delays. However, a $10 million order book and record $130 million pipeline set the stage for a potential turnaround in FY27.

Camplify Holdings slashed its net loss by 95% in FY26, posting a second-half profit driven by cost cuts and the MyWay Mutual insurance launch, setting a foundation for growth in FY27.

Fenix Resources reported a 131% jump in net profit to $12.47 million for FY26, driven by an 87% surge in revenue amid ongoing production ramp-up and infrastructure investments.

Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.